Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000723861 | SCV000203804 | uncertain significance | not provided | 2014-04-03 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000278329 | SCV000449412 | likely benign | Asphyxiating thoracic dystrophy 5 | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
Illumina Laboratory Services, |
RCV000317115 | SCV000449413 | likely benign | Cranioectodermal dysplasia 4 | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
Genetic Services Laboratory, |
RCV000154140 | SCV000597943 | likely benign | not specified | 2015-10-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001083264 | SCV000775129 | benign | Asphyxiating thoracic dystrophy 5; Senior-Loken syndrome 8 | 2025-02-03 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000723861 | SCV001158798 | uncertain significance | not provided | 2024-11-25 | criteria provided, single submitter | clinical testing | The WDR19 c.2792A>C; p.Tyr931Ser variant (rs187546086), to our knowledge, is not reported in the medical literature but is reported in ClinVar (Variation ID: 167843). This variant is found in the general population with an overall allele frequency of 0.27% (768/280184 alleles, including a single homozygote) in the Genome Aggregation Database (v2.1.1). Computational analyses are uncertain whether this variant is neutral or deleterious (REVEL: 0.308). While the relatively high population frequency suggests that this is likely a benign variant, given the lack of clinical and functional data, the significance of this variant is uncertain at this time. |
Genome Diagnostics Laboratory, |
RCV002277304 | SCV002567162 | uncertain significance | Connective tissue disorder | 2021-03-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002516102 | SCV003671888 | uncertain significance | Inborn genetic diseases | 2022-11-18 | criteria provided, single submitter | clinical testing | The c.2792A>C (p.Y931S) alteration is located in exon 25 (coding exon 25) of the WDR19 gene. This alteration results from a A to C substitution at nucleotide position 2792, causing the tyrosine (Y) at amino acid position 931 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Laboratory of Diagnostic Genome Analysis, |
RCV000723861 | SCV001799170 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000154140 | SCV001925398 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000723861 | SCV001967561 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004532742 | SCV004739304 | likely benign | WDR19-related disorder | 2019-05-17 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |